72 kDa type IV collagenase

AltitudeomicsDB
Protein Official symbol MMP2
Aliases MMP2 CLG4A
Chromosomal Location  16
Length 660
Uniprot ID P08253
EC number 3.4.24.24
Protein family Information(Pfam) PF00040;PF00045;PF00413;PF01471;
PDB id 1CK7;1CXW;1EAK;1GEN;1GXD;1HOV;1J7M;1KS0;1QIB;1RTG;3AYU;
InterPro ID IPR028708;IPR000562;IPR036943;IPR000585;IPR036375;IPR018487;IPR018486;IPR013806;IPR033739;IPR024079;IPR001818;IPR021190;IPR021158;IPR006026;IPR002477;IPR036365;IPR036366;
dbSNP rs121912953 rs759302357 rs121912955 rs17859943 rs764961297 rs16955280

Protein Protein Interaction

0%
Download Tab separated file
AltitudeomicsDB
Protein 1 Protein 2 Combine Score
TIMP2 MMP2 0.999
SRC STAT3 0.995
VEGFA STAT3 0.994
MMP2 DCN 0.993
VEGFA SRC 0.987
COL18A1 MMP2 0.985
TIMP3 MMP2 0.985
VEGFA MMP2 0.979
STAT3 MMP2 0.979
MMP2 TIMP1 0.976
SRC MMP2 0.974
VEGFA TIMP1 0.973
ACAN MMP2 0.972
STAT3 TIMP1 0.971
COL1A1 MMP2 0.97
COL1A1 DCN 0.966
COL18A1 COL1A1 0.926
VEGFA COL18A1 0.884
ACAN DCN 0.86
TIMP3 TIMP2 0.762
VEGFA DCN 0.759
ACAN COL1A1 0.744
COL1A1 TIMP1 0.713
VEGFA TIMP2 0.676
ACAN TIMP1 0.672
ACAN TIMP3 0.645
TIMP3 COL1A1 0.628
VEGFA TIMP3 0.603
TIMP3 DCN 0.588
TIMP1 DCN 0.586
TIMP2 COL1A1 0.582
COL18A1 TIMP1 0.569
ACAN TIMP2 0.552
VEGFA ACAN 0.54
TIMP2 DCN 0.526
VEGFA COL1A1 0.518
COL18A1 TIMP2 0.504
COL18A1 TIMP3 0.468
COL18A1 DCN 0.455
Gene Ontology Semantic Similarity
Download Tab separated file
# 7077 (TIMP2) 6714 (SRC) 7422 (VEGFA) 4313 (MMP2) 80781 (COL18A1) 7078 (TIMP3) 6774 (STAT3) 176 (ACAN) 1277 (COL1A1) 7076 (TIMP1) 1634 (DCN)
7077 (TIMP2) 1.00 0.56 0.57 0.41 0.19 0.87 0.46 0.47 0.60 0.97 0.48
6714 (SRC) 0.56 1.00 0.64 0.55 0.18 0.58 0.55 0.56 0.59 0.57 0.58
7422 (VEGFA) 0.57 0.64 1.00 0.56 0.20 0.60 0.58 0.59 0.63 0.61 0.59
4313 (MMP2) 0.41 0.55 0.56 1.00 0.19 0.46 0.44 0.41 0.51 0.44 0.43
80781 (COL18A1) 0.19 0.18 0.20 0.19 1.00 0.20 0.18 0.78 0.61 0.19 0.54
7078 (TIMP3) 0.87 0.58 0.60 0.46 0.20 1.00 0.48 0.55 0.68 0.85 0.56
6774 (STAT3) 0.46 0.55 0.58 0.44 0.18 0.48 1.00 0.47 0.52 0.47 0.54
176 (ACAN) 0.47 0.56 0.59 0.41 0.78 0.55 0.47 1.00 0.87 0.49 0.86
1277 (COL1A1) 0.60 0.59 0.63 0.51 0.61 0.68 0.52 0.87 1.00 0.60 0.76
7076 (TIMP1) 0.97 0.57 0.61 0.44 0.19 0.85 0.47 0.49 0.60 1.00 0.51
1634 (DCN) 0.48 0.58 0.59 0.43 0.54 0.56 0.54 0.86 0.76 0.51 1.00
Association with High Altitude
Protein Official symbol Source Organism Tissue of Expression Level of hypoxia Altitude Duration of experiment Level of expression Fold change Experiment details geographical location ethnicity of the patients Control group Control (Fold change) Reference (PMID)
MMP2 Toad Liver - 3464 m 33 day downregulated -2.153712659 RNA-seq Tibetan Plateau Asiatic toad 1 Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - 28673260
Association with TF
TF TF Entrez Gene Gene Entrez Type PMID Database
CEBPE 1053 MMP2 4313 Activation 17487558 TRUSST
EZH2 2146 MMP2 4313 Unknown 8670251 TRUSST
ATF2 1386 MMP2 4313 Unknown 14610084 TRUSST
ETV5 2119 MMP2 4313 Unknown 12855590 TRUSST
HDAC3 8841 MMP2 4313 Activation 9295016 TRUSST
CREB1 1385 MMP2 4313 Activation 17487558 TRUSST
MZF1 7593 MMP2 4313 Repression 23319049 TRUSST
HOXB7 3217 MMP2 4313 Unknown 11556732 TRUSST
NFKB1 4790 MMP2 4313 Unknown 20729552 TRUSST
ETS2 2114 MMP2 4313 Activation 15235127 TRUSST
KLF4 9314 MMP2 4313 Unknown 14610084 TRUSST
MSC 9242 MMP2 4313 Repression 23319049 TRUSST
ETV4 2118 MMP2 4313 Activation 22632819 TRUSST
HTATIP2 10553 MMP2 4313 Repression 23319049 TRUSST
JUN 3725 MMP2 4313 Unknown 11875117 TRUSST
ATF3 467 MMP2 4313 Unknown 10954416 TRUSST
HIF1A 3091 MMP2 4313 Unknown 8670251 TRUSST
SSX2 6757 MMP2 4313 Unknown 10816578 TRUSST
TP53 7157 MMP2 4313 Unknown 8550612 TRUSST
SP1 6667 MMP2 4313 Unknown 10816578 TRUSST
PAX6 5080 MMP2 4313 Unknown 21878622 TRUSST
RUNX2 860 MMP2 4313 Unknown 10816578 TRUSST
TFAP2C 7022 MMP2 4313 Repression 10585866 TRUSST
NR4A1 3164 MMP2 4313 Activation 17490615 TRUSST
SP3 6670 MMP2 4313 Activation 11435435 TRUSST
TFAP2A 7020 MMP2 4313 Unknown 15191537 TRUSST
TWIST1 7291 MMP2 4313 Unknown 11163768 TRUSST
STAT3 6774 MMP2 4313 Unknown 23599428 TRUSST
RELA 5970 MMP2 4313 Unknown 21878622 TRUSST
SRF 6722 MMP2 4313 Unknown 15790882 TRUSST
YBX1 4904 MMP2 4313 Unknown 19876927 TRUSST
TWIST2 117581 MMP2 4313 Unknown 11163768 TRUSST
Association with miRNA
miRTarBase ID miRNA Species (miRNA) Protein Official Symbol Human Entrez ID Species (Target Gene) Experiments Support Type References (PMID)
MIRT005570 hsa-miR-29b-3p Homo sapiens MMP2 4313 Homo sapiens Microarray Functional MTI (Weak) 22942087
MIRT005570 hsa-miR-29b-3p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay//qRT-PCR//Western blot Functional MTI 20657750
MIRT005570 hsa-miR-29b-3p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay Functional MTI 22745231
MIRT005570 hsa-miR-29b-3p Homo sapiens MMP2 4313 Homo sapiens Western blot Functional MTI 24130681
MIRT005570 hsa-miR-29b-3p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay//qRT-PCR Functional MTI 23354167
MIRT005570 hsa-miR-29b-3p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay//qRT-PCR//Western blot Functional MTI 26063204
MIRT005570 hsa-miR-29b-3p Homo sapiens MMP2 4313 Homo sapiens Immunofluorescence//Immunohistochemistry//Luciferase reporter assay//Northern blot//qRT-PCR//Western blot Functional MTI 24130168
MIRT005570 hsa-miR-29b-3p Homo sapiens MMP2 4313 Homo sapiens Western blot Functional MTI 23254643
MIRT005570 hsa-miR-29b-3p Homo sapiens MMP2 4313 Homo sapiens Western blot Functional MTI 24147037
MIRT005742 hsa-miR-451a Homo sapiens MMP2 4313 Homo sapiens qRT-PCR//Western blot Functional MTI 20816946
MIRT005742 hsa-miR-451a Homo sapiens MMP2 4313 Homo sapiens qRT-PCR//Western blot Functional MTI 27173190
MIRT018099 hsa-miR-335-5p Homo sapiens MMP2 4313 Homo sapiens Microarray Functional MTI (Weak) 18185580
MIRT019228 hsa-miR-338-3p Homo sapiens MMP2 4313 Homo sapiens Western blot;qRT-PCR Non-Functional MTI 21671467
MIRT030716 hsa-miR-21-5p Homo sapiens MMP2 4313 Homo sapiens qRT-PCR Functional MTI (Weak) 19435867
MIRT031370 hsa-miR-17-5p Homo sapiens MMP2 4313 Homo sapiens Western blot Functional MTI 20209605
MIRT053245 hsa-miR-29c-3p Homo sapiens MMP2 4313 Homo sapiens Immunofluorescence//Immunohistochemistry//Luciferase reporter assay//Northern blot//qRT-PCR//Western blot Functional MTI 24130168
MIRT053245 hsa-miR-29c-3p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay//qRT-PCR//Western blot Functional MTI 23936390
MIRT053481 hsa-miR-9-5p Homo sapiens MMP2 4313 Homo sapiens qRT-PCR Functional MTI (Weak) 21931274
MIRT053245 hsa-miR-29c-3p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay Functional MTI 22745231
MIRT053580 hsa-miR-29a-3p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay Functional MTI 22745231
MIRT053245 hsa-miR-29c-3p Homo sapiens MMP2 4313 Homo sapiens qRT-PCR//Western blot Functional MTI 23175151
MIRT053336 hsa-miR-491-5p Homo sapiens MMP2 4313 Homo sapiens Immunohistochemistry//Microarray//qRT-PCR//Western blot Functional MTI 23725476
MIRT053580 hsa-miR-29a-3p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay Functional MTI 26700017
MIRT053580 hsa-miR-29a-3p Homo sapiens MMP2 4313 Homo sapiens Immunofluorescence//Immunohistochemistry//Luciferase reporter assay//Northern blot//qRT-PCR//Western blot Functional MTI 24130168
MIRT053580 hsa-miR-29a-3p Homo sapiens MMP2 4313 Homo sapiens Flow//Luciferase reporter assay//qRT-PCR//Western blot Functional MTI 24210072
MIRT053787 hsa-miR-452-5p Homo sapiens MMP2 4313 Homo sapiens Microarray//qRT-PCR Functional MTI (Weak) 22952876
MIRT437388 hsa-miR-708-5p Homo sapiens MMP2 4313 Homo sapiens Flow//qRT-PCR//Western blot Functional MTI 23754151
MIRT437572 hsa-miR-767-5p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay Functional MTI 22745231
MIRT438153 hsa-miR-106b-5p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay Functional MTI 24164962
MIRT438234 hsa-miR-221-3p Homo sapiens MMP2 4313 Homo sapiens Western blot Functional MTI 24147037
MIRT440222 hsa-miR-544a Homo sapiens MMP2 4313 Homo sapiens HITS-CLIP Functional MTI (Weak) 24374217
MIRT724935 hsa-miR-29b-2-5p Homo sapiens MMP2 4313 Homo sapiens HITS-CLIP Functional MTI (Weak) 19536157
MIRT724933 hsa-miR-1238-3p Homo sapiens MMP2 4313 Homo sapiens HITS-CLIP Functional MTI (Weak) 19536157
MIRT724934 hsa-miR-670-3p Homo sapiens MMP2 4313 Homo sapiens HITS-CLIP Functional MTI (Weak) 19536157
MIRT724937 hsa-miR-6792-3p Homo sapiens MMP2 4313 Homo sapiens HITS-CLIP Functional MTI (Weak) 19536157
MIRT724936 hsa-miR-6749-3p Homo sapiens MMP2 4313 Homo sapiens HITS-CLIP Functional MTI (Weak) 19536157
MIRT724938 hsa-miR-4691-5p Homo sapiens MMP2 4313 Homo sapiens HITS-CLIP Functional MTI (Weak) 19536157
MIRT731453 hsa-miR-125b-5p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay Functional MTI 27133077
MIRT731061 hsa-miR-130b-3p Homo sapiens MMP2 4313 Homo sapiens qRT-PCR//Luciferase reporter assay//Western blot Functional MTI 25154741
MIRT732848 hsa-miR-520g-3p Homo sapiens MMP2 4313 Homo sapiens In situ hybridization//Luciferase reporter assay//qRT-PCR//Western blot Functional MTI 28292471
MIRT733143 hsa-miR-524-5p Homo sapiens MMP2 4313 Homo sapiens qRT-PCR//Western blot Functional MTI 26998102
MIRT733418 hsa-miR-302a-5p Homo sapiens MMP2 4313 Homo sapiens ELISA//Western blot Functional MTI 26191138
MIRT734261 hsa-miR-218-5p Homo sapiens MMP2 4313 Homo sapiens qRT-PCR//Western blot Functional MTI 26133092
MIRT734404 hsa-miR-203a-5p Homo sapiens MMP2 4313 Homo sapiens Western blot Functional MTI 26278219
MIRT734784 hsa-miR-143-3p Homo sapiens MMP2 4313 Homo sapiens qRT-PCR//Western blot Functional MTI 26722463
MIRT734996 hsa-miR-519d-3p Homo sapiens MMP2 4313 Homo sapiens Luciferase reporter assay Functional MTI 25803859
Gene Ontology
ID GO ID GO Term GO Type
4313 GO:0001525 angiogenesis GOTERM_BP_DIRECT
4313 GO:0001666 response to hypoxia GOTERM_BP_DIRECT
4313 GO:0044267 cellular protein metabolic process GOTERM_BP_DIRECT
4313 GO:0005739 mitochondrion GOTERM_CC_DIRECT
4313 GO:0001955 blood vessel maturation GOTERM_BP_DIRECT
4313 GO:0004252 serine-type endopeptidase activity GOTERM_MF_DIRECT
4313 GO:0005886 plasma membrane GOTERM_CC_DIRECT
4313 GO:0048013 ephrin receptor signaling pathway GOTERM_BP_DIRECT
4313 GO:0030017 sarcomere GOTERM_CC_DIRECT
4313 GO:0030574 collagen catabolic process GOTERM_BP_DIRECT
4313 GO:0045089 positive regulation of innate immune response GOTERM_BP_DIRECT
4313 GO:0005634 nucleus GOTERM_CC_DIRECT
4313 GO:0060346 bone trabecula formation GOTERM_BP_DIRECT
4313 GO:0031012 extracellular matrix GOTERM_CC_DIRECT
4313 GO:0007566 embryo implantation GOTERM_BP_DIRECT
4313 GO:0001957 intramembranous ossification GOTERM_BP_DIRECT
4313 GO:0005576 extracellular region GOTERM_CC_DIRECT
4313 GO:0005578 proteinaceous extracellular matrix GOTERM_CC_DIRECT
4313 GO:1904707 positive regulation of vascular smooth muscle cell proliferation GOTERM_BP_DIRECT
4313 GO:0004222 cysteine-type endopeptidase activity GOTERM_MF_DIRECT
4313 GO:0022617 extracellular matrix disassembly GOTERM_BP_DIRECT
4313 GO:0005615 extracellular space GOTERM_CC_DIRECT
4313 GO:0071230 cellular response to amino acid stimulus GOTERM_BP_DIRECT
4313 GO:0005515 protein binding GOTERM_MF_DIRECT
4313 GO:0008270 zinc ion binding GOTERM_MF_DIRECT
4313 GO:0006508 proteolysis GOTERM_BP_DIRECT
4313 GO:0060325 face morphogenesis GOTERM_BP_DIRECT
4313 GO:0035987 endodermal cell differentiation GOTERM_BP_DIRECT
4313 GO:0008237 metallopeptidase activity GOTERM_MF_DIRECT
Pathways
Human Entrez ID KEGG ID KEGG Term
4313 hsa04670 Leukocyte transendothelial migration
4313 hsa04915 Estrogen signaling pathway
4313 hsa04912 GnRH signaling pathway
4313 hsa05200 Pathways in cancer
4313 hsa05219 Bladder cancer
4313 hsa05205 Proteoglycans in cancer
Association with Disease
Protein Official Symbol Human Entrez ID Disease Name Disease Id Disease Semantic Type Semantic score DSI DPI Disease Type
MMP2 4313 Nose Neoplasms C0028433 Neoplastic Process 0.3 0.373 0.862 group
MMP2 4313 Aortic Aneurysm, Thoracic C0162872 Disease or Syndrome 0.54 0.373 0.862 disease
MMP2 4313 Malignant Bone Neoplasm C0279530 Neoplastic Process 0.3 0.373 0.862 disease
MMP2 4313 Testicular Germ Cell Tumor C1336708 Neoplastic Process 0.3 0.373 0.862 disease
MMP2 4313 Glioblastoma Multiforme C1621958 Neoplastic Process 0.35 0.373 0.862 disease
MMP2 4313 Liver Cirrhosis, Alcoholic C0023891 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Neoplasm Invasiveness C0027626 Pathologic Function 0.3 0.373 0.862 phenotype
MMP2 4313 Neoplasm Metastasis C0027627 Neoplastic Process 0.4 0.373 0.862 phenotype
MMP2 4313 Neointima Formation C2936381 Pathologic Function 0.3 0.373 0.862 phenotype
MMP2 4313 Drug-Induced Acute Liver Injury C3658290 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Rheumatoid Arthritis C0003873 Disease or Syndrome 0.4 0.373 0.862 disease
MMP2 4313 Malignant neoplasm of breast C0006142 Neoplastic Process 0.4 0.373 0.862 disease
MMP2 4313 Colorectal Neoplasms C0009404 Neoplastic Process 0.4 0.373 0.862 group
MMP2 4313 Diabetic Neuropathies C0011882 Disease or Syndrome 0.3 0.373 0.862 group
MMP2 4313 Glioblastoma C0017636 Neoplastic Process 0.4 0.373 0.862 disease
MMP2 4313 Maxillary Diseases C0024950 Disease or Syndrome 0.3 0.373 0.862 group
MMP2 4313 Diabetic Asymmetric Polyneuropathy C0393835 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Aortic Diseases C0003493 Disease or Syndrome 0.3 0.373 0.862 group
MMP2 4313 Aortic Rupture C0003496 Disease or Syndrome 0.31 0.373 0.862 disease
MMP2 4313 Colorectal Carcinoma C0009402 Neoplastic Process 0.4 0.373 0.862 disease
MMP2 4313 Inflammation C0021368 Pathologic Function 0.31 0.373 0.862 phenotype
MMP2 4313 Diabetic Mononeuropathy C0271678 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Diabetic Autonomic Neuropathy C0271686 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Craniofacial Abnormalities C0376634 Congenital Abnormality 0.3 0.373 0.862 group
MMP2 4313 Aseptic Necrosis of Bone C0520474 Pathologic Function 0.3 0.373 0.862 phenotype
MMP2 4313 Lupus Nephritis C0024143 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Mandibular Diseases C0024689 Disease or Syndrome 0.3 0.373 0.862 group
MMP2 4313 Cholestasis, Extrahepatic C0005398 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Bone Diseases C0005940 Disease or Syndrome 0.31 0.373 0.862 group
MMP2 4313 Hepatitis, Toxic C0019193 Injury or Poisoning 0.3 0.373 0.862 disease
MMP2 4313 Weight Gain C0043094 Finding 0.3 0.373 0.862 phenotype
MMP2 4313 Urban cutaneous leishmaniasis C0086541 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Panacinar Emphysema C0264393 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Liver carcinoma C2239176 Neoplastic Process 0.4 0.373 0.862 disease
MMP2 4313 Osteosarcoma C0029463 Neoplastic Process 0.4 0.373 0.862 disease
MMP2 4313 Hamman-Rich syndrome C0085786 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Centriacinar Emphysema C0221227 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Fibrosis, Liver C0239946 Disease or Syndrome 0.37 0.373 0.862 disease
MMP2 4313 Tumoral calcinosis C0263628 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Diabetic Polyneuropathies C0271680 Disease or Syndrome 0.3 0.373 0.862 group
MMP2 4313 Cancer of Nose C0751394 Neoplastic Process 0.3 0.373 0.862 disease
MMP2 4313 Alloxan Diabetes C0002152 Experimental Model of Disease 0.3 0.373 0.862 disease
MMP2 4313 Calcinosis C0006663 Pathologic Function 0.3 0.373 0.862 phenotype
MMP2 4313 Liver Cirrhosis C0023890 Disease or Syndrome 0.5 0.373 0.862 disease
MMP2 4313 Marfan Syndrome C0024796 Disease or Syndrome 0.31 0.373 0.862 disease
MMP2 4313 Myocardial Infarction C0027051 Disease or Syndrome 0.53 0.373 0.862 disease
MMP2 4313 Nasopharyngeal Neoplasms C0027439 Neoplastic Process 0.3 0.373 0.862 group
MMP2 4313 Cancer of Nasopharynx C0238301 Neoplastic Process 0.31 0.373 0.862 disease
MMP2 4313 Chemical and Drug Induced Liver Injury C4277682 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Metabolic Bone Disorder C0005944 Disease or Syndrome 0.3 0.373 0.862 group
MMP2 4313 Diabetes Mellitus, Experimental C0011853 Experimental Model of Disease 0.3 0.373 0.862 disease
MMP2 4313 Liver Cirrhosis, Experimental C0023893 Experimental Model of Disease 0.3 0.373 0.862 disease
MMP2 4313 Disease Exacerbation C0235874 Finding 0.3 0.373 0.862 phenotype
MMP2 4313 Neointima C2936380 Acquired Abnormality 0.3 0.373 0.862 phenotype
MMP2 4313 Hypertensive disease C0020538 Disease or Syndrome 0.6 0.373 0.862 group
MMP2 4313 Bone necrosis C0029445 Pathologic Function 0.3 0.373 0.862 phenotype
MMP2 4313 Streptozotocin Diabetes C0038433 Experimental Model of Disease 0.3 0.373 0.862 disease
MMP2 4313 Breast Carcinoma C0678222 Neoplastic Process 0.4 0.373 0.862 disease
MMP2 4313 Diabetic Neuralgia C0751074 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Drug-Induced Liver Disease C0860207 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Chemically-Induced Liver Toxicity C4279912 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Oral Submucous Fibrosis C0029172 Disease or Syndrome 0.31 0.373 0.862 disease
MMP2 4313 Osteopenia C0029453 Disease or Syndrome 0.42 0.373 0.862 disease
MMP2 4313 Focal Emphysema C2350878 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Fetal Growth Retardation C0015934 Pathologic Function 0.31 0.373 0.862 phenotype
MMP2 4313 Avascular necrosis of bone C0027543 Pathologic Function 0.3 0.373 0.862 phenotype
MMP2 4313 Pulmonary Emphysema C0034067 Disease or Syndrome 0.33 0.373 0.862 disease
MMP2 4313 Pulmonary Fibrosis C0034069 Disease or Syndrome 0.32 0.373 0.862 disease
MMP2 4313 Leishmaniasis, New World C0086540 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Diabetic Amyotrophy C0271685 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Symmetric Diabetic Proximal Motor Neuropathy C0271673 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Giant Cell Glioblastoma C0334588 Neoplastic Process 0.3 0.373 0.862 disease
MMP2 4313 Hepatitis, Drug-Induced C1262760 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Mammary Neoplasms C1458155 Neoplastic Process 0.4 0.373 0.862 group
MMP2 4313 Cerebral Hemorrhage C2937358 Pathologic Function 0.3 0.373 0.862 phenotype
MMP2 4313 Bone neoplasms C0005967 Neoplastic Process 0.3 0.373 0.862 group
MMP2 4313 Kienbock Disease C0022682 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Leishmaniasis, Cutaneous C0023283 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Asymmetric Diabetic Proximal Motor Neuropathy C0271674 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Aortic Aneurysm, Thoracoabdominal C0340630 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Microcalcification C0521174 Pathologic Function 0.3 0.373 0.862 phenotype
MMP2 4313 Aortic Aneurysm, Ruptured C0741160 Disease or Syndrome 0.3 0.373 0.862 disease
MMP2 4313 Mammary Neoplasms, Human C1257931 Neoplastic Process 0.3 0.373 0.862 group
MMP2 4313 Nasopharyngeal carcinoma C2931822 Neoplastic Process 0.4 0.373 0.862 disease
MMP2 4313 TORG-WINCHESTER SYNDROME C1850155 Disease or Syndrome 0.78 0.373 0.862 disease
MMP2 4313 Colorectal Cancer C1527249 Neoplastic Process 0.7 0.373 0.862 disease
MMP2 4313 Alcoholic Intoxication, Chronic C0001973 Mental or Behavioral Dysfunction 0.3 0.373 0.862 disease
MMP2 4313 Alcohol abuse C0085762 Mental or Behavioral Dysfunction 0.51 0.373 0.862 disease
Association with Drug
Protein Official Symbol Human Entrez ID drug_claim_primary_name drug_name drug_chembl_id interaction_types
MMP2 4313 4-HYDROPEROXYCYCLOPHOSPHAMIDE PERFOSFAMIDE CHEMBL61511 None
MMP2 4313 AE-941 None None None
MMP2 4313 ARP100 CHEMBL181244 CHEMBL181244 inhibitor
MMP2 4313 BATIMASTAT BATIMASTAT CHEMBL279786 inhibitor
MMP2 4313 AZD6605 None None inhibitor
MMP2 4313 BB-3644 SOLIMASTAT CHEMBL2107228 inhibitor
MMP2 4313 BEVACIZUMAB BEVACIZUMAB CHEMBL1201583 None
MMP2 4313 BMS-275291 REBIMASTAT CHEMBL76222 None
MMP2 4313 BMS 275291 REBIMASTAT CHEMBL76222 inhibitor
MMP2 4313 CGS-27023A CGS-27023A CHEMBL514138 inhibitor
MMP2 4313 CHLORHEXIDINE CHLORHEXIDINE CHEMBL790 None
MMP2 4313 CHONDROITIN CHONDROITIN SULFATE CHEMBL2303614 None
MMP2 4313 COL-3 INCYCLINIDE CHEMBL2104970 None
MMP2 4313 CSA CYCLOSPORINE CHEMBL160 None
MMP2 4313 G-CSF FILGRASTIM CHEMBL1201567 None
MMP2 4313 HEPARAN SULFATE None None None
MMP2 4313 ILOMASTAT ILOMASTAT CHEMBL19611 inhibitor
MMP2 4313 IL-2 None None None
MMP2 4313 IMMUNOSUPPRESSIVE None None None
MMP2 4313 LETROZOLE LETROZOLE CHEMBL1444 None
MMP2 4313 MARIMASTAT MARIMASTAT CHEMBL279785 None
MMP2 4313 MARIMASTAT MARIMASTAT CHEMBL279785 None
MMP2 4313 MARIMASTAT MARIMASTAT CHEMBL279785 inhibitor
MMP2 4313 METASTAT INCYCLINIDE CHEMBL2104970 inhibitor
MMP2 4313 MUSTARD None None None
MMP2 4313 NEOVASTAT None None inhibitor
MMP2 4313 PACLITAXEL PACLITAXEL CHEMBL428647 None
MMP2 4313 PG-116800 None None inhibitor
MMP2 4313 PRINOMASTAT PRINOMASTAT CHEMBL75094 inhibitor
MMP2 4313 POLYPHENOL None None None
MMP2 4313 PRINOMASTAT PRINOMASTAT CHEMBL75094 vaccine
MMP2 4313 PRAVASTATIN PRAVASTATIN CHEMBL1144 None
MMP2 4313 RAMIPRIL RAMIPRIL CHEMBL1168 None
MMP2 4313 RESVERATROL RESVERATROL CHEMBL165 None
MMP2 4313 RETINOID ETRETINATE CHEMBL464 None
MMP2 4313 S-3304 None None vaccine
MMP2 4313 RO-26-2853 None None inhibitor
MMP2 4313 SB-3CT None None inhibitor
MMP2 4313 SIMVASTATIN SIMVASTATIN CHEMBL1064 None
MMP2 4313 SERMS None None None
MMP2 4313 STREPTOZOTOCIN STREPTOZOTOCIN CHEMBL1651906 None
MMP2 4313 TANOMASTAT TANOMASTAT CHEMBL261932 inhibitor
MMP2 4313 TANOMASTAT TANOMASTAT CHEMBL261932 inhibitor
MMP2 4313 TILUDRONIC ACID TILUDRONIC ACID CHEMBL1350 inhibitor
MMP2 4313 TST10088 None None None
MMP2 4313 VINBLASTINE VINBLASTINE CHEMBL159 None